Skip to main content

Table 2 Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form Scoresa Over Time, Aripiprazole Lauroxil Group

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

 

Week 5

Week 13

Week 25

All patients (observed cases)

 Total score, n

73

65

57

  Mean (SD)

48.7 (11.2)

48.7 (10.1)

49.0 (11.5)

 Satisfaction with Medication, n

67

63

52

  Mean (SD)

3.9 (1.0)

3.8 (1.0)

3.8 (0.9)

 Overall Life Satisfaction, n

73

65

57

  Mean (SD)

3.9 (1.0)

3.7 (0.9)

3.8 (1.0)

Patients who completed 25 weeks of treatmentb

 Total score, n

57

57

57

  Mean (SD)

49.2 (10.3)

49.1 (9.3)

49.0 (11.5)

 Satisfaction with Medication, n

52

55

52

  Mean (SD)

4.0 (0.8)

3.9 (0.9)

3.8 (0.9)

 Overall Life Satisfaction, n

57

57

57

  Mean (SD)

3.8 (0.9)

3.7 (0.9)

3.8 (1.0)

  1. aMaximum total score: 70
  2. bAll patients who had Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form data at weeks 5 and 25